Skip to main content

Day: July 8, 2020

Walter Candelu Joins SAFR From RealNetworks As Area Vice President For The Middle East

SEATTLE, July 08, 2020 (GLOBE NEWSWIRE) — SAFR® from RealNetworks, Inc. (NASDAQ: RNWK), the world’s premier facial recognition and computer vision platform for live video, today announced the addition of Walter Candelu as Area Vice President for the Middle East. Mr. Candelu brings experience and leadership to the new SAFR office in Dubai. He will drive its growing sales and business development initiatives across the Middle East Region. Mr. Candelu will be based in Dubai, UAE and will focus on expanding the SAFR reseller channel, partner network, and regional sales and marketing programs. Prior to joining SAFR, he held senior positions with leading security companies where he successfully drove the exponential growth of their technical capabilities and revenue. Most recently he was the Head of Sales and Business Development for...

Continue reading

Allstate Expands Personal Lines Market Position with Acquisition of National General

NORTHBROOK, Ill., July 07, 2020 (GLOBE NEWSWIRE) — The Allstate Corporation (NYSE: ALL) has agreed to acquire National General Holdings Corporation for approximately $4 billion in cash, or $34.50 per share. The transaction is expected to close in early 2021, subject to regulatory approvals and other customary closing conditions.“Acquiring National General accelerates Allstate’s strategy to increase market share in personal property-liability and significantly expands our independent agent distribution,” said Tom Wilson, Chair, President and CEO. “The acquisition increases personal lines premiums by $4.0 billion and market share by over 1 percentage point to 10%. National General’s business and technology platforms will be utilized to further strengthen Allstate’s existing independent agent businesses. The transaction will be accretive...

Continue reading

Vir Biotechnology Announces Pricing of Public Offering of Common Stock

SAN FRANCISCO, July 07, 2020 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on treating and preventing serious infectious diseases, today announced the pricing of its previously announced underwritten public offering of 7,142,857 shares of its common stock at a price to the public of $42.00 per share. The gross proceeds to Vir from the offering before deducting the underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $300.0 million. The offering is expected to close on July 10, 2020, subject to satisfaction of customary closing conditions. In addition, Vir has granted the underwriters a 30-day option to purchase up to 1,071,428 additional shares of its common stock.Goldman Sachs & Co. LLC, BofA Securities, Cowen and Barclays...

Continue reading

Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs

COPENHAGEN, Denmark, July 07, 2020 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to address unmet medical needs, today announced the pricing of its underwritten public offering of 4,225,352 American Depositary Shares (“ADSs”), each of which represents one ordinary share of Ascendis, at a price to the public of $142.00 per ADS. All of the ADSs are being offered by Ascendis. The offering is expected to close on or about July 10, 2020 subject to customary closing conditions. In addition, Ascendis has granted the underwriters a 30-day option to purchase up to an additional 633,802 ADSs at the public offering price, less the underwriting commissions.Ascendis estimates net proceeds from the offering to be approximately $569.2 million (assuming no exercise...

Continue reading

89bio Announces Pricing of Upsized Public Offering of Common Stock

SAN FRANCISCO, July 07, 2020 (GLOBE NEWSWIRE) — 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today announced the pricing of an upsized underwritten public offering of 2,649,600 shares of its common stock at a public offering price of $27.50 per share. The gross proceeds of the offering, before deducting the underwriting discount and other offering expenses payable by 89bio, are expected to be approximately $72.9 million. All of the shares are being offered by 89bio.  In addition, 89bio has granted the underwriters a 30-day option to purchase up to an additional 397,440 shares of common stock at the public offering price, less the underwriting discounts and commissions. The offering...

Continue reading

Kaixin Auto Holdings Announces Unaudited 2019 Financial Results

BEIJING, July 07, 2020 (GLOBE NEWSWIRE) — Kaixin Auto Holdings (“Kaixin” or the “Company”) (NASDAQ: KXIN), one of the primary dealership networks in the premium used car segment in China, today announced its unaudited financial results for the twelve months ended December 31, 2019. The Company anticipates to file its 2019 Form 20-F with the SEC within 5 days of this announcement. The delay in our filing is mainly due to additional work in preparation of our financial statements involving retroactive adjustments to prior years’ equity accounts as a result of the consummation of the reverse recapitalization on April 30, 2019.2019 Financial HighlightsTotal net revenues were US$334.7 million, representing a decrease of 22.4% from US$431.4 million in 2018.Gross loss was US$5.5 million, compared with a gross profit...

Continue reading

Itaú Corpbanca Schedules Second Quarter 2020 Financial Results, Conference Call and Webcast

SANTIAGO, Chile, July 07, 2020 (GLOBE NEWSWIRE) — ITAÚ CORPBANCA (NYSE: ITCB; SSE: ITAUCORP) announced today that it will release its results for the second quarter ended June 30, 2020, before the market opens in Santiago and in New York on Friday, July 31, 2020.On Monday, August 3, 2020, at 11:00 A.M. Santiago time (11:00 A.M. ET), the Company’s management team will host a conference call to discuss the financial results. The call will be hosted by Gabriel Moura, Itaú Corpbanca’s Chief Executive Officer and Claudia Labbé, Itaú Corpbanca’s Head of Investor Relations.Conference Call Details:Participant registration: http://www.directeventreg.com/registration/event/6775796Upon registering, each participant will be provided with call details and a registrant ID used to track attendance on the conference call. Reminders will also be...

Continue reading

Cordy Oilfield Services Inc. Reports First Quarter 2020 Results

CALGARY, Alberta, July 07, 2020 (GLOBE NEWSWIRE) — CORDY OILFIELD SERVICES INC. (the “Corporation” or “Cordy”) (CKK: TSX-V) released today its first quarter 2020 results.FIRST QUARTER ENDED MARCH 31, 2020For the three month period ended March 31, 2020, Cordy’s consolidated revenues increased by 48 percent, from the comparative period in 2019. Cordy’s consolidated operating earnings increased $0.5 million or 49 percent from the comparative period. Cordy’s net income was $0.9 million for the three months ended March 31, 2020, as compared to $0.3 million for the three months ended March 31, 2019, representing a 199% increase over the prior period.The Environmental Services segment saw a significant increase in revenue for the three month period ended March 31, 2020, from the comparative period in 2019. The increase was...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.